Nayar, Utthara
Cohen, Ofir
Kapstad, Christian
Cuoco, Michael S.
Waks, Adrienne G. http://orcid.org/0000-0001-5649-7229
Wander, Seth A.
Painter, Corrie
Freeman, Samuel
Persky, Nicole S.
Marini, Lori
Helvie, Karla
Oliver, Nelly
Rozenblatt-Rosen, Orit
Ma, Cynthia X.
Regev, Aviv
Winer, Eric P.
Lin, Nancy U.
Wagle, Nikhil http://orcid.org/0000-0003-3332-9438
Article History
Received: 30 October 2017
Accepted: 23 October 2018
First Online: 10 December 2018
Competing interests
: N.W. was previously a stockholder in Foundation Medicine, was previously a consultant for Novartis, and has received sponsored research support from Novartis and Puma Biotechnology. N.U.L. has received research funding from Genentech, Cascadian Therapeutics, Array Biopharma, Novartis and Pfizer. C.X.M. receives consulting fees from Puma Biotechnology, Novartis and Pfizer, and research funding from Puma Biotechnology and Pfizer. S.A.W. is a consultant for Foundation Medicine and InfiniteMD. E.P.W. is a consultant for InfiniteMD, Genentech and Eli Lilly. A.R. is a scientific advisory board member of ThermoFisher Scientific, Syros Pharmaceuticals and Driver Group and a founder of Celsius Therapeutics. None of these entities had any role in the conceptualization, design, data collection, analysis, decision to publish or preparation of the manuscript.